OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial intelligence and immunotherapy
Parnian Jabbari, Nima Rezaei
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 7, pp. 689-691
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Nanoparticle-mediated cancer cell therapy: basic science to clinical applications
Jaya Verma, Caaisha Warsame, Rajkumar Kottayasamy Seenivasagam, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 601-627
Open Access | Times Cited: 56

Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine
Maurizio Cè, Giovanni Irmici, Chiara Foschini, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 2673-2701
Open Access | Times Cited: 48

The emerging roles of artificial intelligence in cancer drug development and precision therapy
Guosheng Liang, Wenguo Fan, Hui Luo, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 128, pp. 110255-110255
Open Access | Times Cited: 115

Applying artificial intelligence for cancer immunotherapy
Zhijie Xu, Xiang Wang, Shuangshuang Zeng, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3393-3405
Open Access | Times Cited: 64

mRNA therapeutics: New vaccination and beyond
Huanhuan Wei, Liangliang Zheng, Zefeng Wang
Fundamental Research (2023) Vol. 3, Iss. 5, pp. 749-759
Open Access | Times Cited: 35

Artificial intelligence-assisted selection and efficacy prediction of antineoplastic strategies for precision cancer therapy
Zhe Zhang, Xiawei Wei
Seminars in Cancer Biology (2023) Vol. 90, pp. 57-72
Closed Access | Times Cited: 24

Artificial Intelligence in Brain Tumour Surgery—An Emerging Paradigm
Simon C. Williams, Hugo Layard Horsfall, Jonathan P. Funnell, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 5010-5010
Open Access | Times Cited: 53

The combination of artificial intelligence and systems biology for intelligent vaccine design
Giulia Russo, Pedro A. Reche, Marzio Pennisi, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 11, pp. 1267-1281
Open Access | Times Cited: 51

Artificial Intelligence in Vaccine and Drug Design
Sunil Thomas, Ann Abraham, Jeremy Baldwin, et al.
Methods in molecular biology (2021), pp. 131-146
Closed Access | Times Cited: 39

Next-Generation Vaccine Development with Nanomaterials: Recent Advances, Possibilities, and Challenges
Shamitha Shetty, Pablo Cordero Alvarado, Deleah Pettie, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 273-306
Closed Access | Times Cited: 5

Role of AI in empowering and redefining the oncology care landscape: perspective from a developing nation
Isha Goel, Yogendra Bhaskar, Nand Kumar, et al.
Frontiers in Digital Health (2025) Vol. 7
Open Access

T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
Fleur S. Peters, Jonathan C. Strefford, Eric Eldering, et al.
Haematologica (2021) Vol. 106, Iss. 5, pp. 1234-1243
Open Access | Times Cited: 29

A Study of the Recent Trends of Immunology: Key Challenges, Domains, Applications, Datasets, and Future Directions
Sharnil Pandya, Aanchal Thakur, Santosh Saxena, et al.
Sensors (2021) Vol. 21, Iss. 23, pp. 7786-7786
Open Access | Times Cited: 24

Construction by artificial intelligence and immunovalidation of hypoallergenic mite allergen Der f 36 vaccine
Qiaozhi Qin, Jian Tang, Cai-Yun Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Leveraging the wheat germ cell-free protein synthesis system to accelerate malaria vaccine development
Bernard N. Kanoi, Hikaru Nagaoka, Masayuki Morita, et al.
Parasitology International (2020) Vol. 80, pp. 102224-102224
Open Access | Times Cited: 24

Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents
Amal Alqahtani
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 10

Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?
Geoffrey Alan Watson, Jeffrey Doi, Aaron R. Hansen, et al.
British Journal of Clinical Pharmacology (2020) Vol. 86, Iss. 9, pp. 1753-1768
Open Access | Times Cited: 14

Artificial intelligence in the treatment of cancer: Changing patterns, constraints, and prospects
Mohammad Ali, Shahid Ud Din Wani, Tathagata Dey, et al.
Health and Technology (2024) Vol. 14, Iss. 3, pp. 417-432
Closed Access | Times Cited: 1

Artificial Intelligence, Big Data, and Regulation of Immunity: Challenges and Opportunities
Bhagirath Singh, Anthony M. Jevnikar, Eric Desjardins
Archivum Immunologiae et Therapiae Experimentalis (2024) Vol. 72, Iss. 1
Open Access | Times Cited: 1

Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India
Sreyashi Majumdar, Rohit Verma, Avishek Saha, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 6

BIG DATA IN HEALTH AND OPEN SCIENCE: A CONTRIBUTION TO THE MANAGEMENT OF KNOWLEDGE IN COVID-19
Jorge Lima de Magalhães, Zulmira Hartz, Luc Quoniam, et al.
Revista Prevenção de Infecção e Saúde (2020) Vol. 6
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top